Lanean...
Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy
CDK4 & 6 inhibitors have enhanced the effectiveness of endocrine therapy (ET) in patients with advanced breast cancer (ABC). This paper presents exploratory analyses examining patient and disease characteristics that may inform in whom and when abemaciclib should be initiated. MONARCH 2 and 3 en...
Gorde:
| Argitaratua izan da: | NPJ Breast Cancer |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group UK
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299082/ https://ncbi.nlm.nih.gov/pubmed/30588487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41523-018-0094-2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|